• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Germany·Basic Materials·EVK.DE
Share

Evonik Industries AG Stocks

€ 20.98Last Updated 08.10.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

€ 10.83B

€ 20.98
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Slightly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

14.09.2026 13:35

How Investors Can Profit from Europe’s Problems: 10 Stocks and the Polish Market

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Evonik Industries AG operates primarily in the specialized chemicals market. Its business activities are structured across five principal divisions: Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure. The Specialty Additives segment is responsible for delivering essential ingredients such as polyurethane additives, modified silicones, isophorones, epoxy hardeners, oil modifiers, fumed silicas, matting agents, TAA compounds, and acetylenic diol-based surfactants, which find use in consumer products and various industrial applications. In the Nutrition & Care division, Evonik provides compounds like amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, amino acids and their derivatives, synthetic products, pharmaceutical-grade polymers, and DL-methionine. These are crucial for consumer goods, animal nutrition, and healthcare industries. The Smart Materials segment manufactures advanced substances including hydrogen peroxide, peracetic acid, various activated nickel and precious metal catalysts (for powder, oil, and fat hydrogenation), amorphous polyalphaolefins, polybutadienes, polyester resins, thermoplastic and reactive methacrylate resins, PEEK, polyamide 12, organosilanes, chlorosilanes, and different types of silicas (fumed and precipitated). These serve a broad spectrum of industries including automotive, paints, coatings, adhesives, and construction. Through its Performance Materials segment, the company produces polymer materials and intermediate chemicals, including butene-1, DINP, isononanol, cyanuric chloride, alkoxides, and superabsorbents, specifically for the rubber, plastics, and automotive sectors. Lastly, the Technology & Infrastructure segment provides crucial internal services, encompassing site management, utilities and waste disposal, technical expertise, process technology, engineering, and logistics. Evonik maintains a significant international presence, with operations spanning across the Asia-Pacific region, Europe, the Middle East, Africa, Central and South America, and North America. Founded in 1873, the firm's main offices are located in Essen, Germany, and it functions as a subsidiary of RAG-Stiftung.

Company Valuation

Slightly undervalued
5/7

Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'cheap' on

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of EVK.DE is 17.9 and suggests 14.9% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

09.10.2026 13:23

What makes Physical Intelligence—the company Bezos has invested in—so interesting?

09.10.2026 13:07

Three of Freedom's subsidiaries have asked AIX to approve a bond program of up to $1 billion

09.10.2026 12:19

The Uzbek fintech startup Uzum may enter the international debt market

09.10.2026 12:04

The wave of IPO cancellations continues: one of Australia's largest IPOs has fallen through

09.10.2026 11:55

Analysts predict a 40% rise in Halyk Bank's stock price and the highest dividends in the region

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026